Literature DB >> 9415999

Caldesmon.

P A Huber1.   

Abstract

Caldesmon is a protein that is found in smooth muscle and in non-muscle cells. Two isoform classes produced by alternative splicing of one gene have been characterized. The smooth muscle, high molecular weight (89-93 kDa), caldesmon isoforms are exclusively found in adult and fully differentiated smooth muscle cells. The non-muscle, low molecular weight (59-63 kDa), caldesmon isoforms are found in non-muscle and in de-differentiated smooth muscle cells. The conserved regions of all isoforms contain caldesmon's properties such as binding to actin, tropomyosin, Ca(2+)-calmodulin, myosin and phospholipids. All isoforms are also very potent inhibitors of the actin-tropomyosin activated myosin MgATPase. Non-muscle and smooth muscle isoforms of caldesmon perform different roles in vivo. This may be reflected by the distinct cellular distribution of these isoform classes. Non-muscle caldesmon is a regulatory factor in the microfilament network and is thus involved in the assembly and stabilization of microfilaments. Smooth muscle caldesmon together with tropomyosin is a mediating factor for Ca(2+)-dependent inhibition of smooth muscle contraction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415999     DOI: 10.1016/s1357-2725(97)00004-6

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  29 in total

Review 1.  Actin and the smooth muscle regulatory proteins: a structural perspective.

Authors:  J L Hodgkinson
Journal:  J Muscle Res Cell Motil       Date:  2000-02       Impact factor: 2.698

Review 2.  Calponin (CaP) as a latch-bridge protein--a new concept in regulation of contractility in smooth muscles.

Authors:  Pawel T Szymanski
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

3.  Mutant Caldesmon lacking cdc2 phosphorylation sites delays M-phase entry and inhibits cytokinesis.

Authors:  S Yamashiro; H Chern; Y Yamakita; F Matsumura
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

4.  Hypoxia-increased expression of genes involved in inflammation, dedifferentiation, pro-fibrosis, and extracellular matrix remodeling of human bladder smooth muscle cells.

Authors:  Bridget Wiafe; Adetola Adesida; Thomas Churchill; Esther Ekpe Adewuyi; Zack Li; Peter Metcalfe
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-09-08       Impact factor: 2.416

5.  Histochemical localization of caldesmon in the CNS and ganglia of the mouse.

Authors:  Christoph N Köhler
Journal:  J Histochem Cytochem       Date:  2011-03-16       Impact factor: 2.479

6.  Quantitative proteomics analysis of parthenogenetically induced pluripotent stem cells.

Authors:  Zhe Hu; Lei Wang; Zhensheng Xie; Xinlei Zhang; Du Feng; Fang Wang; Bingfeng Zuo; Lingling Wang; Zhong Liu; Zhisheng Chen; Fuquan Yang; Lin Liu
Journal:  Protein Cell       Date:  2011-09-09       Impact factor: 14.870

7.  Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms.

Authors:  Carmen E Gacchina; Partha Deb; Jeremy L Barth; Anand Ramamurthi
Journal:  Tissue Eng Part A       Date:  2011-05-09       Impact factor: 3.845

8.  HIV-1-infected astrocytes and the microglial proteome.

Authors:  Tong Wang; Nan Gong; Jianuo Liu; Irena Kadiu; Stephanie D Kraft-Terry; Joshua D Schlautman; Pawel Ciborowski; David J Volsky; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-28       Impact factor: 4.147

Review 9.  Gene therapy targeting glaucoma: where are we?

Authors:  Xuyang Liu; Carol A Rasmussen; B'ann T Gabelt; Curtis R Brandt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

10.  The actin-binding protein caldesmon is in spleen and lymph nodes predominately expressed by smooth-muscle cells, reticular cells, and follicular dendritic cells.

Authors:  Christoph N Köhler
Journal:  J Histochem Cytochem       Date:  2010-02       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.